The French stock market has been buoyed by optimism surrounding potential interest rate cuts from both the Federal Reserve and the European Central Bank, with major indices like the CAC 40 seeing notable gains. This positive sentiment is further supported by increased business activity driven by events such as the upcoming Paris Olympics. In this favorable economic climate, growth companies with high insider ownership can be particularly appealing to investors. Such companies often demonstrate strong alignment between management and shareholder interests, which can be crucial for sustained revenue growth.
Name | Insider Ownership | Earnings Growth |
Groupe OKwind Société anonyme (ENXTPA:ALOKW) | 24.8% | 36% |
VusionGroup (ENXTPA:VU) | 13.4% | 25.7% |
Adocia (ENXTPA:ADOC) | 11.9% | 63% |
Icape Holding (ENXTPA:ALICA) | 30.2% | 35.1% |
Arcure (ENXTPA:ALCUR) | 21.4% | 27.5% |
La Française de l'Energie (ENXTPA:FDE) | 19.9% | 31.9% |
S.M.A.I.O (ENXTPA:ALSMA) | 17.4% | 35.2% |
Munic (ENXTPA:ALMUN) | 29.2% | 149.2% |
OSE Immunotherapeutics (ENXTPA:OSE) | 25.6% | 5.9% |
MedinCell (ENXTPA:MEDCL) | 15.8% | 93.9% |
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, and furniture markets across Northern Europe, Southern Europe, the Americas, and the Asia Pacific with a market cap of €1.07 billion.
Operations: Revenue segments (in millions of €): Americas: 172.65, Asia-Pacific: 118.54, Segment Adjustment: 209.13
Insider Ownership: 19.6%
Revenue Growth Forecast: 10.4% p.a.
Lectra has shown robust growth potential with revenue for the first half of 2024 at €262.29 million, up from €239.55 million a year ago, though net income slightly decreased to €12.51 million. Analysts forecast significant annual earnings growth of 29.3% over the next three years, outpacing the French market's 12.2%. The stock is trading at a substantial discount of 45.8% below its estimated fair value and is expected to rise by 22.4%.
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A. is a pharmaceutical company in France that specializes in developing long-acting injectables across various therapeutic areas, with a market cap of €537.54 million.
Operations: MedinCell generates €11.95 million in revenue from its pharmaceuticals segment.
Insider Ownership: 15.8%
Revenue Growth Forecast: 46.2% p.a.
MedinCell reported a net loss of €25.04 million for the fiscal year ending March 31, 2024, an improvement from the previous year's €32.01 million loss. Revenue was down to €11.95 million from €13.66 million last year, but analysts forecast revenue growth at 46.2% per year, significantly above market averages and expected profitability within three years despite negative shareholders' equity and no recent insider trading activity.
Simply Wall St Growth Rating: ★★★★★★
Overview: VusionGroup S.A. offers digitalization solutions for commerce across Europe, Asia, and North America with a market cap of €2.29 billion.
Operations: The company's revenue from installing and maintaining electronic shelf labels is €801.96 million.
Insider Ownership: 13.4%
Revenue Growth Forecast: 21.3% p.a.
VusionGroup's revenue is forecast to grow 21.3% annually, significantly outpacing the French market average of 5.8%. Earnings are expected to rise by 25.7% per year, also surpassing the market average of 12.2%. Recent partnerships with Ace Hardware and Hy-Vee highlight VusionGroup’s innovative digital shelf label technology, enhancing operational efficiencies and customer experience across thousands of stores. Analysts predict a stock price increase of 35.4%, reflecting strong growth potential driven by technological advancements and strategic collaborations.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com